The IDSA provides guidelines on drug resistant TB [1]
References
- P. Nahid, S.R. Mase, G.B. Migliori, G. Sotgiu, G.H. Bothamley, J.L. Brozek, A. Cattamanchi, J.P. Cegielski, L. Chen, C.L. Daley, T.L. Dalton, R. Duarte, F. Fregonese, C.R. Horsburgh, F. Ahmad Khan, F. Kheir, Z. Lan, A. Lardizabal, M. Lauzardo, J.M. Mangan, S.M. Marks, L. McKenna, D. Menzies, C.D. Mitnick, D.M. Nilsen, F. Parvez, C.A. Peloquin, A. Raftery, H.S. Schaaf, N.S. Shah, J.R. Starke, J.W. Wilson, J.M. Wortham, T. Chorba, and B. Seaworth, "Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline", American Journal of Respiratory and Critical Care Medicine, vol. 200, pp. e93-e142, 2019. http://dx.doi.org/10.1164/rccm.201909-1874ST